The CBI has booked a Central Drug Standard Control Organisation (CDSCO) inspector and others for allegedly demanding bribe to ignore the deficiency in samples of dobutamine injection produced by an Amritsar-based pharma company. The drug is used to treat acute heart failure.
Those accused in the FIR are inspector Ankur Bansal, Kwality Pharmaceutical Limited managing director Ramesh Arora, its director Ajay Kumar Arora and chief pharmacist Karunakar Tiwari, besides unknown public servants.
The CBI registered the case following a source information about alleged conspiracy between certain CDSCO officials, working under the Health & Family Welfare Ministry, and owners/representatives of companies manufacturing drugs to manage adverse test results.
The agency alleges that samples of the injection manufactured by the Kwality Pharmaceuticals Limited (Amritar) were collected by CDSCO for testing. They failed the test after which its managing director challenged the reports.
On July 18, it is alleged, Mr. Tiwari — in connivance with Mr. Arora, approached the drug inspector for a favourable decision. The inspector assured him of getting the matter settled and later informed Mr. Tiwari that injection samples had again failed the tests.
